“It will take multiple therapies to make ALS a treatable disease” Cimbura said. “With the recent approval of AMX0035 [Amylyx’s Relyvrio ], review of tofersen … and now NurOwn, we can be on our way to that goal.” https://t.co/soNHOBjsTY
Had you been part of a credible, *unbiased* #ALS organization (instead of speaking like a child while your job is to help dying people), maybe you could have. My, how things have changed in #ALS' leadership. Thankfully.
#endals@TheKuldipDave@alsassociation@statnews#NUROWN
As someone who participated in the @BrainstormCell#NurOwn trial and received six additional treatments under EAP, I am excited to share my firsthand experience at the upcoming @US_FDA AdComm. The biomarker data fully supports the benefits that I felt while on treatment.
We are hitting the road again!! Join us and if you want updates on where we are screening next, sign up for emails at https://t.co/sz846iTjlR
Looking forward to continuing to bring more people into the fight!!!